A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants
Clinical trial NCT06493409 · COMPLETED
Trial details
- NCT number
- NCT06493409
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-26
- Primary completion
- 2024-12-07
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.